Get the Daily Brief
Latest Biotech News
TCG Crossover Closes $1.3 Billion Fund Targeting Biopharma Investments Amid Market Shifts
TCG Crossover (TCGX), a prominent life sciences investment firm, successfully closed its third fund at $1.3 billion, raising total capital to $3.1 billion across multiple funds. The firm aims to...
Nobel Prize Honors Regulatory T Cell Discoveries: Autoimmune Disease Insights
The 2025 Nobel Prize in Physiology or Medicine was awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking work on regulatory T cells (T-regs). Their discoveries...
AstraZeneca and Algen Ink $555M AI Drug Discovery Deal in Immunology
AstraZeneca has entered a strategic partnership with San Francisco-based Algen Biotechnologies, agreeing to pay up to $555 million to leverage Algen's AI-driven AlgenBrain platform. This platform...
Skye Bioscience’s Obesity Drug Trial Fails Primary Endpoint, Combo Shows Promise
Skye Bioscience disclosed topline phase 2a data for Nimacimab, a peripherally restricted CB1 receptor inhibitor antibody targeting obesity. The monotherapy arm failed to meet its primary weight...
Nanoparticle Therapy Restores Blood-Brain Barrier, Reverses Alzheimer’s in Mice
A collaborative team led by the Institute for Bioengineering of Catalonia and West China Hospital developed bioactive supramolecular nanoparticles that modulate blood-brain barrier (BBB) transport...
Lund University Uncovers SLAMF6 Role in AML Immune Evasion, Antibody Restores T Cell Function
Researchers at Lund University identified a novel immune escape mechanism in acute myeloid leukemia (AML) involving the surface protein SLAMF6, expressed in approximately 60% of AML cases but...
Insilico Medicine Unveils AI Workflow LEGION to Explore Vast Drug Space and Protect Discoveries
Artificial intelligence-driven drug developer Insilico Medicine introduced LEGION, an AI workflow designed to exhaustively generate and cover chemical space around the NLRP3 inflammatory target,...
Asimov Launches Stable Producer Cell Lines to Scale AAV Gene Therapy Manufacturing
Asimov introduced its AAV Edge Stable Producer system, a platform generating stable HEK293 cell lines with integrated viral genes for adeno-associated virus (AAV) vector production, aiming to...
FDA Pilot Program Expedites Review of Generic Drugs Using Domestic Ingredients
The U.S. Food and Drug Administration (FDA) initiated a pilot program to accelerate regulatory review for generic drugs manufactured and tested entirely with domestically sourced active...
Regencell’s Stock Swells on Speculative Surge, Despite No FDA Approvals
Regencell Bioscience Holdings, a Hong Kong-based biotech focused on Traditional Chinese Medicine (TCM) treatments for neurocognitive disorders, experienced an extraordinary stock rally in 2025,...
FDA Greenlights UCLA’s AD-NP1 Heart Regeneration Drug: Clinical Trials Begin
The FDA has approved the novel therapeutic AD-NP1 developed by UCLA cardiologists, targeting a protein that inhibits tissue regeneration in vital organs such as the heart and kidneys. This...
Skye Bioscience’s Nimacimab Falters in Phase 2 Obesity Trial – Combination Therapy Shows Promise
Skye Bioscience’s obesity drug nimacimab, a peripherally restricted CB1 receptor inhibitor antibody, failed to meet the primary endpoint in a 26-week Phase 2a trial as monotherapy, resulting in a...
Arbor Biotechnologies and Chiesi Seal Over $2 Billion Deal for Gene Editing Rare Disease Therapies
Arbor Biotechnologies has entered a landmark partnership with Chiesi Group, granting exclusive global rights and up to $2.1 billion in payments for the development and commercialization of ABO-101...
Asimov Launches Stable AAV Producer Cell Lines to Boost Gene Therapy Manufacturing
Asimov has unveiled its AAV Edge Stable Producer system, a synthetic biology breakthrough that stably integrates viral genes into HEK293 cells to produce high-titer AAV vectors without transient...
AstraZeneca and Daiichi Sankyo’s Datroway Extends Survival in Difficult-to-Treat Triple-Negative Breast Cancer
Datroway, AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate, showed prolonged survival in patients with advanced triple-negative breast cancer who are ineligible for immunotherapy. This...
Breakthroughs in AI for Cancer Prognosis and Toxicity Prediction Enhance Precision Oncology
Advanced artificial intelligence models are making significant strides in oncology by predicting patient outcomes and treatment toxicities across cancer types. Using transformer models with...
Nobel Prize Honors Discovery of Regulatory T Cells Transforming Autoimmune Disease Understanding
The 2025 Nobel Prize in Physiology or Medicine was jointly awarded to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their seminal work elucidating regulatory T cells (T-regs), a class of...
Geisinger MyCode’s ‘Genomic-First’ Approach Identifies Undiagnosed Rare Disease Variants
Researchers at Geisinger applied a genomic-first strategy analyzing exome sequences from over 218,000 participants, uncovering pathogenic variants in 2.5% of individuals across 490 rare disease...
Precision Neuro's Minimally Invasive Brain-Computer Interface Demonstrates Early Feasibility
The brain-computer interface system developed by Precision Neuroscience Corp. shows promising capability to capture high-resolution neural signals and stimulate brain regions without damaging the...
CareDx Secures IVDR Certification for Advanced Transplant Compatibility Testing Platforms
CareDx announced successful IVDR certification in the European Union for its AlloSeq Tx and QType platforms, which leverage next-generation sequencing and RT-PCR technologies for enhanced human...